c-myc, not her-2/ neu, can predict the prognosis of breast cancer patients : how novel, how accurate, and how significant?
The predictive and prognostic implication of oncogene amplification in breast cancer has received great attention in the past two decades. her-2/neu and c-myc are two oncogenes that are frequently amplified and overexpressed in breast carcinomas. Despite the extensive data on these oncogenes, their...
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2003
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/1822/1924 |
| País: | Portugal |
| Oai: | oai:repositorium.sdum.uminho.pt:1822/1924 |